The Medical Device Manufacturers Association (MDMA) announced today that Leslie Trigg, Outset Medical Chair and CEO, was elected as the new Chair of the MDMA Board of Directors during the 2022 Annual Meeting.
“Medical technology innovators are at the forefront of improving patient outcomes and reducing the cost of care, and I am honored to lead MDMA as they continue their tremendous work as the leading voice of our industry,” said Trigg. “Modern technology is impacting when, where and how healthcare can be delivered. Together, we have the privilege of imagining what the future of healthcare could look like, and turning invention into reality.”
“For 30 years, MDMA has been dedicated to serving innovative and entrepreneurial medical technology companies, and this dynamic ecosystem is poised to solve some of the most pressing issues facing patient care in the years to come,” said Mark Leahey, President and CEO of MDMA. “Leslie is an amazing leader whose vision will help guide MDMA and our industry over the challenges and opportunities facing the delivery of healthcare in 21st century.”
Trigg highlighted the importance of shortening the gap between the regulatory process and securing reimbursement, and the successful implementation of the MDUFA V agreement as some of the board’s top priorities over the coming years.
Trigg follows the successful three-year tenure of Jeff McCaulley, CEO of Avalign Technologies, Inc., who oversaw the full repeal of the medical device tax, as well as the MDUFA V negotiations. She was named as the new Chair during another successful MDMA Annual Meeting where medical technology executives heard from HHS Secretary Xavier Becerra, CMS Chief Medical Officer Dr. Lee Fleisher, Senators Amy Klobuchar and Todd Young, Representatives Anna Eshoo and Suzan DelBene, and many more.